MESONEPHRIC-LIKE ADENOCARCINOMA
Clinical trials for MESONEPHRIC-LIKE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MESONEPHRIC-LIKE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for MESONEPHRIC-LIKE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells target Hard-to-Treat cancers in new trial
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (TROP2 CAR-NK) delivered directly into the abdomen. It is for people with ovarian cancer that no longer responds to platinum chemotherapy, as well as certain rare ovarian and pancreatic cancers. The goal is …
Matched conditions: MESONEPHRIC-LIKE ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
Rare cancer registry launches to unlock secrets of MLA
Knowledge-focused Recruiting nowThis study is creating a database of medical information from 2,000 people with mesonephric-like adenocarcinoma (MLA), a very rare type of uterine cancer. Researchers hope to learn more about how MLA behaves and what makes it different from other cancers. No treatments or tests a…
Matched conditions: MESONEPHRIC-LIKE ADENOCARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:04 UTC